share_log

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC 溫賴特 & 有限公司.維持購買天然,將目標價格降低至 2.5 美元
Benzinga Real-time News ·  2023/01/30 06:44

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celularity (NASDAQ:CELU) with a Buy and lowers the price target from $15 to $2.5.

HC Wainwright&Co.分析師Swayampakula Ramakanth維持Celulality(納斯達克代碼:CELU)為買入,並將目標價從15美元下調至2.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論